Cancer News and Research

Latest Cancer News and Research

Smoking and tobacco-cessation campaign to be launched by Texas and Mexico institutions

The University of Texas MD Anderson Cancer Center, the National Institute of Cancer of the United Mexican States, and the Commission of National Institutes and High Specialty Hospitals joined forces today in Mexico City, signing an agreement to develop prevention and control programs to reduce tobacco use in the United States and Mexico, with a focus on Mexican and Mexican-American youth.

30 Nov 2012

Wichita State professor hopes to understand how cancer cells spread and become fatal

Through her research at Wichita State University, assistant chemistry professor Moriah Beck hopes to understand how cancer cells spread and become fatal.

30 Nov 2012

Viewpoints: GOP attack on Medicare, Medicaid could hurt critical programs; Will says Obama is repeating his overreach on health care

Congressional Republicans are insisting that big cuts to Medicare and Medicaid be on the table in the negotiations over the so-called fiscal cliff and deficit reduction. That stance is largely a political move against two programs, which have been critical to the public welfare for the past half-century.

30 Nov 2012

JQ1 cancer drug may be useful in purging latent HIV infection

Breakthrough drugs have made it possible for people to live with HIV longer than ever before, but more work must be done to actually cure the disease. One of the challenges researchers face involves fully eradicating the virus when it is latent in the body.

30 Nov 2012

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis will highlight more than 140 presentations on key data from its extensive oncology portfolio at the leading year-end scientific meetings devoted to hematology and breast cancer, demonstrating continued innovation in research and development efforts to advance the care of patients with cancer and rare diseases.

30 Nov 2012

Cleveland Clinic researcher names American Association for the Advancement of Science Fellow

Cleveland Clinic researcher Jun Qin, Ph.D., has been named a Fellow of the American Association for the Advancement of Science (AAAS). As part of the Molecular Cardiology Department in the Lerner Research Institute, Qin was elected as an AAAS Fellow for exemplary contributions to the field of cell signaling.

30 Nov 2012

Fn14 gene plays a role in growth and spread of non-small cell lung cancer tumors

Lung cancer researchers at St. Joseph's Hospital and Medical Center in Phoenix, Ariz., in collaboration with researchers at the Translational Genomics Research Institute and other institutions, have identified a gene that plays a role in the growth and spread of non-small cell lung cancer tumors, opening the door for potential new treatment options.

30 Nov 2012

Boehringer Ingelheim announces new data from volasertib Phase I/II leukemia study

Boehringer Ingelheim today announced that new data evaluating volasertib, an investigational polo-like kinase (Plk) inhibitor, will be presented at the 54th American Society of Hematology (ASH) annual meeting taking place December 8-11 in Atlanta, Ga.

30 Nov 2012

DARA BioSciences submits KRN5500 Orphan Drug Application with FDA

DARA BioSciences, Inc., a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it has submitted an Orphan Drug Application to the U.S. Food and Drug Administration (FDA) for KRN5500, a compound in development to treat a painful form of chronic chemotherapy-induced peripheral neuropathy (CCIPN).

30 Nov 2012

New detection method can identify genetic switches associated with breast cancer

Physicians may now be better at detecting breast cancer than ever before, but much more work remains to ensure accurate diagnosis is possible and especially to assess future risk. That's why researchers from Germany have been working to develop a new test of gene action to predict cancer risk both at first diagnosis and into the future.

30 Nov 2012

Aduro completes enrollment in CRS-207 and GVAX pancreas cancer vaccine Phase 2 trial

Aduro BioTech, Inc. announces completion of enrollment in the Phase 2 clinical trial of the sequential administration of two cancer vaccines, Aduro's CRS-207 and GVAX Pancreas Cancer Vaccine, in patients with metastatic pancreatic cancer.

30 Nov 2012

Novel SIRT2 inhibitor protects against neuronal damage in animal models of Huntington's

Treatment with a novel agent that inhibits the activity of SIRT2, an enzyme that regulates many important cellular functions, reduced neurological damage, slowed the loss of motor function and extended survival in two animal models of Huntington's disease.

30 Nov 2012

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC).

30 Nov 2012

Varian's TrueBeam receives Indian AERB clearance for use in advanced radiosurgical treatments

Varian Medical Systems has received regulatory clearance from the Indian Atomic Energy Regulatory Board for the use of its unique TrueBeam High Intensity Mode for advanced radiosurgical treatments.

29 Nov 2012

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).

29 Nov 2012

AstraZeneca receives FDA approval for Cometriq to treat medullary thyroid cancer

The U.S. Food and Drug Administration today approved Cometriq (cabozantinib) to treat medullary thyroid cancer that has spread to other parts of the body (metastasized).

29 Nov 2012

Ponatinib thwarts T315I gene mutation in chronic myeloid leukemia

A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial reported in the current edition of The New England Journal of Medicine.

29 Nov 2012

Combination of blood test and whole-genome sequencing technology could screen cancers

Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.

29 Nov 2012

DLKI-DIO3 miRNA cluster suppresses spread of cancer from its primary site

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a group of what have been considered relatively minor regulators in the body that band together to suppress the spread of cancer from its primary site.

29 Nov 2012

Infants of mothers born in the Philippines have low birth weights

Babies born in Ontario to mothers from the Philippines have significantly lower birth weights than those whose mothers were born in Canada or elsewhere in East Asia and are twice as likely to be classified as small for their gestational age, a new study has found.

29 Nov 2012

Cancer News and Research

Latest Cancer News and Research

Smoking and tobacco-cessation campaign to be launched by Texas and Mexico institutions

Wichita State professor hopes to understand how cancer cells spread and become fatal

Viewpoints: GOP attack on Medicare, Medicaid could hurt critical programs; Will says Obama is repeating his overreach on health care

JQ1 cancer drug may be useful in purging latent HIV infection

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Cleveland Clinic researcher names American Association for the Advancement of Science Fellow

Fn14 gene plays a role in growth and spread of non-small cell lung cancer tumors

Boehringer Ingelheim announces new data from volasertib Phase I/II leukemia study

DARA BioSciences submits KRN5500 Orphan Drug Application with FDA

New detection method can identify genetic switches associated with breast cancer

Aduro completes enrollment in CRS-207 and GVAX pancreas cancer vaccine Phase 2 trial

Novel SIRT2 inhibitor protects against neuronal damage in animal models of Huntington's

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

Varian's TrueBeam receives Indian AERB clearance for use in advanced radiosurgical treatments

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

AstraZeneca receives FDA approval for Cometriq to treat medullary thyroid cancer

Ponatinib thwarts T315I gene mutation in chronic myeloid leukemia

Combination of blood test and whole-genome sequencing technology could screen cancers

DLKI-DIO3 miRNA cluster suppresses spread of cancer from its primary site

Infants of mothers born in the Philippines have low birth weights

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in